Search

Your search keyword '"Lewden, C."' showing total 147 results

Search Constraints

Start Over You searched for: Author "Lewden, C." Remove constraint Author: "Lewden, C."
147 results on '"Lewden, C."'

Search Results

10. Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes

11. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ('Three I's') and HIV-Tuberculosis Service Integration in Lower Income Countries

12. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

14. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

15. Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery

16. The incidence of AIDS-defining illnesses at a current CD4 count ≥200 cells/μL in the post-combination antiretroviral therapy era

17. CD4 cell count and the risk of AIDS or death in HIV-Infected adults oncombination antiretroviral therapy with a suppressed viral load: a longitudinalcohort study from COHERE

18. Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe

19. Risk of triple-class virological failure in children with HIV: a retrospective cohort study

20. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?

21. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

22. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

23. Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

29. Lopinavir/ritonavir chez le patient infecté par le VIH en situation d'échec virologique prolongé: évolution immunovirologique et tolérance chez 121 patients de la cohorte ANRS CO8 Aproco-Copilote

31. Causes de décès par hépatopathie en France en 2005 des adultes infectés par le VIH: enquête Mortavic 2005 en collaboration avec Mortalité 2005, ANRS-EN19

34. A4-3 - Sélection des patients infectés par le VIH avec la durée de suivi la plus longue : analyse de robustesse de l’étude de l’association entre la délétion CCR5 delta 32 et la réponse virologique au traitement antirétroviral

42. Causes de mortalité des patients infectés par le VIH à l'ère des multithérapies : étude rétrospective au sein d'une cohorte de 2 500 patients (1998–1999)

44. Impact of Early versus Late Adherence to Highly Active Antiretroviral Therapy on Immuno-Virological Response: A 3-Year Follow-Up Study

45. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

47. Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration.

48. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.

49. Reasons for hospitalization in HIV-infected children in West Africa.

50. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era.

Catalog

Books, media, physical & digital resources